In the hours leading up to the recent ceasefire between the U.S. and Iran, pro-regime AI-generated videos flooded social ...
AbbVie today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting (San Juan, ...